Robert F. Probst
Thanks, Matt. I'll start with a review of how we see our market as we head into the fourth quarter. As we expected, the U.S. market improved in Q3 from the growth dip we called out in Q2. There was no material improvement in European markets, which remained relatively stagnant. However, we did see some unanticipated market dynamics, namely continued slowing in emerging markets, as others have discussed, and a slowdown in Australia as the election season exacerbated an already uncertain consumer environment. As we move through the fourth quarter, our assumption is that we'll see gradual improvements in Australia and slow recovery in emerging markets. Based on these assumptions, we continue to estimate our global market footprint will grow in the range of 3% for the full year. Now I'll walk through the numbers for the third quarter, starting at the top line. Net sales for Q3 of $599 million were off 4% on both a reported and comparable basis, which adjusts for foreign exchange and the impact of M&A. As Matt indicated earlier, our comparable sales were impacted by discrete factors largely related to timing that collectively reduced our Q3 sales by 7 points. Let me unpack that. The timing of sales in the U.S. adversely impacted sales by 3 points of growth as distributors brought down inventory levels. The timing of sales in emerging markets within the second half accounted for 2 points, together with 1 point from challenging comparisons in India. And the timing of sales in Australia, due to the reduction in trade inventories by a major customer, impacted sales by 1 point. I'll come back to these timing issues and their implications for Q4 when I discuss our outlook. Outside of these timing issues, the performance headwinds related to Australia and the U.S. ready-to-serve cocktails category further impacted the top line. Year-to-date, reported net sales growth was 3%. On a comparable basis, sales for the 9 months were up 1%, reflecting market outperformance in both North America and EMEA, partly offset by lower sales in APSA. We estimate that India and sales timing in emerging markets in Australia collectively reduced year-to-date sales by about 3 points of growth. Favorable mix benefited both quarterly and full year sales. Turning to operating income. Operating income was $145 million for the quarter, down 11%. And on a before charges/gains basis, OI was down 10% to $148 million. The Q1 operating margin increase continued to unwind in the quarter. Gross margins for the quarter were better than expected due to the timing of costs, despite the fact that, as anticipated, we faced a significant Q3 headwind largely due to the timing of raw material-related costs, foreign exchange and a challenging comparison in EMEA. Brand investment was slightly ahead of sales. SG&A in Q3 was down, reflecting ongoing cost containment. On a year-to-date basis, OI before charges/gains was up 6%, benefiting from sales growth and 60 basis points of year-to-date margin expansion driven by gross margin expansion and timing of BI spend. Moving now to income from continuing operations. On a reported basis, income from continuing operations was $85 million or $0.52 per diluted share compared to $98 million or $0.61 per share for the third quarter of 2012. Reported net income in the quarter reflected a net charge of $0.07 per share, principally reflecting a loss on early extinguishment of debt related to our bond repurchases in the quarter and the organizational restructuring noted earlier, partly offset by net charges and gains related to the true-up of acquisition-related reserves. Excluding charges and gains, third quarter income from continuing operations was $96 million or $0.59 per diluted share. That's versus $0.63 in the prior year period and reflected the lower sales, the timing of raw material-related costs and a challenging comparison in the EMEA segment, partly offset by a tax planning benefit of $0.02 per share, which resulted in the lower effective tax rate in the quarter. Through the first 3 quarters of 2013, diluted earnings per share before charges/gains is up 8%. Turning to Beam's segment performance. I'll start with a reminder that our reported segment results under GAAP exclude charges and gains. Results, unless otherwise noted, are on a constant-currency basis, which adjusts for foreign exchange. And we also present sales on a comparable basis, which, in addition to adjusting for FX, also adjusts for acquisitions and divestitures. Starting with North America. Q3 sales came in at $375 million, off 1% on both a reported and comparable basis, reflecting the factors we called out before, namely distributor inventory unwind and performance of the ready-to-serve cocktails segment. We estimate the distributor inventory work-down reduced North America's quarterly comparable sales by 5%. Sales grew at a double-digit rate in North America for premium whiskey at Jim Beam, Maker's Mark, Basil Hayden's and Laphroaig. Another strong quarter in Mexico contributed to North America's results. As Matt indicated earlier, Q3 consumer sell-through data was quite a bit stronger than sell-in despite lower sales for Skinnygirl, and we're encouraged that U.S. sell-through accelerated in our largest premium categories. Demand for our Bourbon Brands further strengthened. Our Tequila portfolio showed continued momentum, and despite the unwind of inventories, Pinnacle Vodka performed very well in the marketplace, with consumption estimated to be up double digits. North America's operating income for the quarter was off 4% to $101 million, reflecting the lower sales in the phasing of brand investment. Year-to-date sales in North America are up 4% on a comparable basis and reflect modest market outperformance led by our Bourbon Brands, partly offset by the lower sales of ready-to-serve cocktails. Operating income in North America is up 12% year-to-date, reflecting strong sales, favorable price mix and the leverage of SG&A expense. Moving to Europe/Middle East/Africa, or EMEA, our Q3 sales were $120 million, up 3% on a comparable basis as we continue to outperform across Europe. EMEA's results reflected double-digit growth for Jim Beam, Laphroaig and Maker's Mark and very good growth for Courvoisier and Teacher's, partly offset by lower sales of local brands in Spain. Geographically, Germany, our second largest Bourbon export market, delivered another quarter of strong growth. Our Bourbon strategy is firing on all cylinders in Germany and across the rest of EMEA, led by Jim Beam, the German market's leading North American whiskey. In Germany, Jim Beam White is up double digits year-to-date. Red Stag and Devil's Cut continue to add strong incremental growth, and Jim Beam Honey has really taken off, capturing more than 75% of the honey whiskey market. It was also a very good sales quarter in Russia, Central Europe and travel retail. Sales were stable in the U.K., and while sales were off in Spain against tough comp, we've significantly outperformed that challenging market year-to-date. OI in EMEA was $27 million for the quarter, off 5% in constant currency, reflecting a challenging comparison that benefited from a nontax -- non-income tax settlement we called out last year. Year-to-date, comparable sales in EMEA are up 4% and operating income is up 7%, reflecting strong top line outperformance and operating leverage. And turning to our APSA segment, Asia Pacific/South America, which is our smallest segment, but still an important one. Even considering a tough lap against strong results in the year ago quarter, APSA's results were below our expectations with Q3 sales of $104 million, down 20% on a comparable basis. Given the size of this decline, I want to spend a few minutes unpacking the drivers and discussing their impact. In the quarter, we saw 3 timing-related factors that collectively had an adverse impact on APSA sales of 16 points: one, the India comparison; two, the timing of sales within the second half in somewhat softer emerging markets; and three, the adjustment of trade inventory levels in a slower Australian market. Let me walk you through each of these timing- and performance-related dynamics. First, India. This is the adverse comparison factor we've previously called out, and it accounted for about 3 points of Q3 impact to APSA. Amidst the internal compliance review we've previously discussed, our team has worked hard to rebuild our commercial position in India, and we expect to return to growth in this attractive market, albeit against a lower base here in Q4. Second, the emerging markets, where the timing of shipments adversely impacted APSA sales by an estimated 7 points. I'd remind you that the timing of shipments in emerging markets can be volatile as these swings can be magnified quarter-to-quarter based on shipment patterns into these markets. We expect the timing of shipments in emerging markets will be a benefit in Q4. At the same time, we also saw a slowing in emerging markets, as others have reported, which further impacted sales. And third, in Australia, we saw the market slow with the weight of macroeconomic factors, combined with consumer uncertainty prior to the Australian elections in September. That resulted in a timing-related challenge as a major customer reduced trade inventories in a lower market. That impacted APSA's Q3 by approximately 6 points of growth. Beyond that, our results in Australia trailed our expectations as price competition intensified in a softer market. We have moved rapidly to make tactical adjustments to our trading strategy. And combined with aggressive innovation, these initiatives give us confidence that we'll perform better in Australia in Q4. Operating income for the quarter in APSA was $23 million, down 26%, reflecting the challenging top line and adverse mix, driven by soft sales of Australia RTD products. Year-to-date, comparable sales in APSA are off 10%, and operating income was 18% lower. The impact of India, inventory movements in Australia and timing of shipments in emerging markets reduced year-to-date sales in APSA by an estimated 10%, roughly half of which is attributable to India. Turning now to the comparable sales performance of our key brands, which we present on a year-to-date basis. Comparable net sales for our Power Brands are up 2% through the first 9 months of the year. As a reminder, that's lapping 11% growth for the first 9 months of 2012. Comparable sales for Jim Beam are up 3% as double-digit year-to-date growth in North America and EMEA has been partly offset by lower sales of RTD products in Australia. Excluding RTD products, year-to-date global sales for the Jim Beam trademark are up at a double-digit rate. Sales growth for Jim Beam accelerated in both North America and EMEA in the quarter, driven by strong growth for the core Jim Beam White Label product, augmented by the brand's innovations led by Red Stag, Devil's Cut and Honey, which continue to grow in the brand's key markets around the world. Given Jim Beam's excellent trends, we're very excited about the brand's forthcoming Make History campaign. Maker's Mark comparable sales are 17% higher year-to-date. This iconic brand continues to inspire strong demand, both on- and off-premise, while we continue to drive higher pricing and favorable mix. As we continue to carefully manage supplies of this brand, we're making the infrastructure investments necessary to expand future production [indiscernible] demand so we continue to see healthy growth going forward in both the U.S. and key international markets. Sauza, the world's #2 tequila, is up 3% through the first 9 months. The brand has performed well in Mexico, and its sell-through performance accelerated in the U.S., where premium innovations led by 100% agave Sauza Blue and Sparkling Margarita continue to help the brand gain market share. Comparable sales of Pinnacle Vodka are up 2% year-to-date, impacted in the quarter by the U.S. distributor inventory unwind and a challenging comparison to last year's 22% increase. While shipment sales may not reach double-digit growth for 2013 due to the distributor inventory movements, we've seen excellent consumption trends for Pinnacle with depletion revenues to retailers up at a double-digit rate for the year. That includes exceptionally strong growth for the base unflavored Pinnacle Vodka, which recently won Best-Tasting Vodka at the International Wine & Spirit Competition. We're also encouraged by the recent launch of new Pinnacle flavors, including the return of limited-edition Pumpkin Pie that performed well last year and the upcoming launch of Pinnacle Cinnamon here in the fourth quarter. So we're pleased with Pinnacle's performance in the marketplace and its long-term growth prospects. We're on pace to achieve our targeted acquisition cost synergies amounting to 20% or more of net sales ahead of schedule. We completed the sales of bottling plants in May and earlier this month, and we anticipate completing the transition of Pinnacle bottling to our facility in Kentuky on schedule in 2014. Canadian Club is up 10% through the first 9 months and has been a bright spot in Australia, where it delivered sustained double-digit growth for the brands' ready-to-drink products. In the quarter, we're pleased that CC earned honors for Australia's Best RTD category Advertising Campaign of the Year and remains the fastest-growing RTD brand in the Australian market. Comparable sales for Courvoisier were off 7% through September versus 15% growth a year ago. Year-to-date growth in the U.K. and Russia partially offset the headwinds in China, where reduced gift-giving has impacted all Cognac producers. The availability of more Cognac due to reduced China demand has also intensified price competition in the travel retail channel. In light of the reversal of the aforementioned emerging market timing issues, we anticipate improved results for Courvoisier in Q4. Teacher's Scotch remained down for the year, off 22% as the brand lapped the final quarter of challenging comparisons in India. As such, we expect Teacher's will benefit in Q4 from a favorable comparison, as well as the timing of shipments in Brazil. Comparable net sales for our Rising Star brands are off 4%, principally reflecting lower sales for Skinnygirl. Our superpremium whiskey Rising Stars are up double digits. As we've discussed, weakness in the ready-to-serve cocktails segment in the U.S. has driven the 29% year-to-date decline for Skinnygirl, which is broadly in line with what we saw at midyear. We expect comparisons to ease somewhat in Q4 given the seasonality of many RTS products. The brand continued to perform better in the vodka and wine categories, which accounted for about 40% of the brand's consumer sales, with wine supported by the recent launch of Skinnygirl Prosecco in wine varietals. Comparable sales for our small batch Bourbons, Knob Creek and Basil Hayden's, are up 15% and 34%, respectively. And Laphroaig, the world's #1 Islay Single Malt Scotch, is up 15%. Hornitos Tequila plays an important role in our Tequila portfolio as our high-end premium brand, and comparable sales are up 8% year-to-date as Hornitos benefited from our brand-building investments, including successful new packaging and positioning and strength across its range. Cruzan Rum is up 1% against a double-digit comp, and shipment sales of our Irish whiskey brands are off 24% against a tough comparison, with pipeline sales following the acquisition. That said, our Kilbeggan family of brands has demonstrated excellent sell-through in the marketplace off a small base, up more than 40% according to the latest Nielsen Data. Comparable sales for Sourz are 8% lower against double-digit growth last year. The brand gained momentum in the quarter, and we've just launched a new advertising campaign for Sourz in its core European markets that we anticipate will bring new energy to the brand. Year-to-date comparable sales for our Local Jewels are down 6%, largely due to challenging conditions in Spain and softness in U.S. cordials, while our Value Creators are down 4%. A few final items before Matt closes things out. Return on invested capital before charges/gains came in at 7%, including intangibles; and, excluding intangibles, was 23%. That's on a trailing 12-month basis. Our tax rate for the quarter came in at 24.5% before charges/gains due to a benefit from our tax-planning initiatives. In light of our year-to-date tax rate, we're now turning a full year tax rate in the range of 27%. Our full year target assumes no major tax changes in our key geographies, such as recently proposed changes in France. Looking at our balance sheet, given our phasing of earnings in 2013, our free cash flow target for the year is now in the range of $275 million to $325 million. Our net debt-to-EBITDA ratio now stands at 2.6x compared to 3.2x a year ago, and our share repurchase authorization remains at 3 million shares. I'll conclude with a few comments about our outlook for the balance of the year. On the top line, we're targeting growth ahead of our market in Q4. As we noted, several timing factors that affected us in Q3, principally in APSA, will benefit Q4. We expect the timing of emerging markets within the second half, which negatively impacted Q3 by about 2 points, will largely unwind in Q4. The timing of sales in Australia, due to trade inventory reductions by a major customer, affected Q3 by about 1 point. This impact will likely begin to unwind to the benefit of Q4, though the inventory level of trade customers is not in our control and could take longer to play out. In Q4, we'll also begin to lap our India repositioning and return to growth there. Keep in mind, that will be off a lower base due to the repositioning of the business we undertook in Q4 of last year. All that said, while we feel good about our consumption trends in North America, our Q4 shipments will cycle against a strong growth in the year ago quarter, and a key Q4 holiday selling season globally will have an important impact on our overall growth in the quarter. Moving down the P&L to operating margins. First, Q4 faces a residual pressure of the unwind of the 300-basis-point improvement from Q1 as we did not see as much unwind in Q3 due to timing. Regarding brand investment, we said we expect BI growth to be roughly in line with sales growth for the year at a healthy mid-teens reinvestment rate. We'll leverage SG&A by achieving the high end of our Fueling Our Growth agenda to achieve 1% to 2% savings in COGS and SG&A. We now expect a full year adverse impact from foreign exchange of about $8 million at the OI line, with the majority hitting in Q4, which translates to an EPS headwind of approximately $0.04 or 2 points of growth. Finally, in terms of earnings per share, we continue to expect below-the-line leverage from OI to earnings per share in Q4 and for the full year, benefiting in Q4 from our refinancing and, for the full year, also benefiting from the lower effective tax rate. We're holding to the lower end of the high single-digit target we established at the start of the year, and we anticipate it returning to solid EPS growth in Q4. Now back to Matt for some closing comments.